Liquidia Co. (NASDAQ:LQDA) Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp lifted its holdings in Liquidia Co. (NASDAQ:LQDA) by 3.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 188,584 shares of the company’s stock after acquiring an additional 6,034 shares during the quarter. Bank of New York Mellon Corp’s holdings in Liquidia were worth $2,218,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Walleye Trading LLC boosted its holdings in shares of Liquidia by 54.7% in the third quarter. Walleye Trading LLC now owns 13,201 shares of the company’s stock worth $132,000 after buying an additional 4,670 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Liquidia by 43.5% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,708 shares of the company’s stock valued at $187,000 after acquiring an additional 5,669 shares in the last quarter. DMC Group LLC raised its position in Liquidia by 17.4% during the fourth quarter. DMC Group LLC now owns 16,302 shares of the company’s stock valued at $192,000 after acquiring an additional 2,419 shares in the last quarter. Intech Investment Management LLC bought a new position in Liquidia during the third quarter valued at approximately $195,000. Finally, Catalina Capital Group LLC raised its position in shares of Liquidia by 6.5% in the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company’s stock valued at $215,000 after purchasing an additional 1,125 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Wells Fargo & Company assumed coverage on shares of Liquidia in a research report on Friday, December 20th. They issued an “overweight” rating and a $20.00 price target on the stock. HC Wainwright reissued a “buy” rating and issued a $29.00 price target on shares of Liquidia in a research report on Thursday. Scotiabank lifted their price target on shares of Liquidia from $30.00 to $34.00 and gave the company a “sector outperform” rating in a research report on Thursday. Finally, Needham & Company LLC boosted their target price on shares of Liquidia from $19.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of $26.63.

Liquidia Price Performance

Shares of LQDA stock opened at $15.12 on Friday. The stock has a market cap of $1.28 billion, a PE ratio of -9.28 and a beta of 0.07. The stock has a 50-day moving average of $14.79 and a 200-day moving average of $12.18. Liquidia Co. has a one year low of $8.26 and a one year high of $16.99.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.08). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The business had revenue of $2.92 million during the quarter, compared to analyst estimates of $4.60 million. As a group, research analysts anticipate that Liquidia Co. will post -1.51 earnings per share for the current year.

Insider Activity at Liquidia

In other Liquidia news, CFO Michael Kaseta sold 23,370 shares of the company’s stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total transaction of $275,298.60. Following the completion of the transaction, the chief financial officer now owns 401,755 shares of the company’s stock, valued at $4,732,673.90. This represents a 5.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Roger Jeffs sold 22,343 shares of the company’s stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total value of $263,200.54. Following the transaction, the chief executive officer now directly owns 1,019,177 shares of the company’s stock, valued at approximately $12,005,905.06. This trade represents a 2.15 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 71,245 shares of company stock worth $843,326. 30.10% of the stock is owned by company insiders.

Liquidia Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).